ARCHIVES

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

UICC Announces Grant Programs to Continue

April 15, 1977

Breast Cancer Survivors Who Take Aspirin Have 50% Reduced Risk Of Metastasis

February 26, 2010

NCA Approves Draft of New Outstanding Investigator Grants

February 10, 1984

Reauthorization Still Held up

September 30, 1988

ASH Highlights: Improved Treatments For NHL, Poor Prognostic Factors For B-Cell In Children

January 30, 2004

NCI-Approved Group, Center Clinical Trials Listed

May 25, 2007